GPER-1 expression is associated with a decreased response rate to primary tamoxifen therapy of breast cancer patients
出版年份 2020 全文链接
标题
GPER-1 expression is associated with a decreased response rate to primary tamoxifen therapy of breast cancer patients
作者
关键词
-
出版物
ARCHIVES OF GYNECOLOGY AND OBSTETRICS
Volume 301, Issue 2, Pages 565-571
出版商
Springer Science and Business Media LLC
发表日期
2020-01-03
DOI
10.1007/s00404-019-05384-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- G-protein-coupled estrogen receptor GPER-1 expression in hormone receptor-positive breast cancer is associated with poor benefit of tamoxifen
- (2018) Tanja Ignatov et al. BREAST CANCER RESEARCH AND TREATMENT
- GPER-1/GPR30 a novel estrogen receptor sited in the cell membrane: therapeutic coupling to breast cancer
- (2017) Luis Molina et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer
- (2017) Qiao Liu et al. Molecular Cancer
- Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer
- (2014) Martin Sjöström et al. BREAST CANCER RESEARCH AND TREATMENT
- GPER functions as a tumor suppressor in MCF-7 and SK-BR-3 breast cancer cells
- (2014) Christine Weißenborn et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- GPER functions as a tumor suppressor in triple-negative breast cancer cells
- (2014) Christine Weißenborn et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The G Protein-Coupled Estrogen Receptor (GPER) Is Expressed in Two Different Subcellular Localizations Reflecting Distinct Tumor Properties in Breast Cancer
- (2014) Eleftherios P. Samartzis et al. PLoS One
- GPER-1 Expression Decreases During Breast Cancer Tumorigenesis
- (2013) Tanja Ignatov et al. CANCER INVESTIGATION
- G Protein-Coupled Estrogen Receptor Is Apoptotic and Correlates with Increased Distant Disease-Free Survival of Estrogen Receptor-Positive Breast Cancer Patients
- (2013) S. Broselid et al. CLINICAL CANCER RESEARCH
- GPER-1 acts as a tumor suppressor in ovarian cancer
- (2013) Tanja Ignatov et al. Journal of Ovarian Research
- Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy
- (2012) Nehmat Houssami et al. EUROPEAN JOURNAL OF CANCER
- G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer
- (2011) Atanas Ignatov et al. BREAST CANCER RESEARCH AND TREATMENT
- The G Protein-Coupled Receptor GPR30 Inhibits Proliferation of Estrogen Receptor-Positive Breast Cancer Cells
- (2010) E. A. Ariazi et al. CANCER RESEARCH
- Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21 and induction of G2 cell-cycle arrest
- (2010) Q K Y Chan et al. CELL DEATH AND DIFFERENTIATION
- Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells
- (2009) Atanas Ignatov et al. BREAST CANCER RESEARCH AND TREATMENT
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started